Three Novel Radiological Indicators for Diagnosis of Adult Acetabular Dysplasia
1 other identifier
observational
200
1 country
1
Brief Summary
Acetabular dysplasia often accompanies by acetabular bone hyperplasia and osteonecrosis of the femoral head. These pathological changes can alter the position of the center of the femoral head. Thus, measurement errors will be generated on the anteroposterior radiographs of the adult pelvis involving centre-edge angle, acetabular angle (Sharp angle), and acetabular head index, eventually resulting in the inaccurate diagnosis of acetabular dysplasia. Herein, the investigators describe the protocol to verify three novel X-ray indicators, including offshoring index (OFI), moving up index (MUI) and teardrop baseline offshoring index (TBOI) of the femoral head. All data will be expressed as relative ratios, as the investigators expect to make an accurate diagnosis through avoiding the generation of errors resulting from measurement angles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 17, 2018
CompletedFirst Posted
Study publicly available on registry
May 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedMay 30, 2018
May 1, 2018
1.7 years
May 17, 2018
May 17, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The sensitivity of offshoring index (OFI)
The sensitivity represents the percentage of actual patients who are correctly diagnosed with a disease. A higher sensitivity indicates a higher rate of correct diagnosis for acetabular dysplasia.
One day after hospitalization
Secondary Outcomes (5)
The specificity of OFI,MUI and TBOI
One day after hospitalization
The positive predictive value of OFI,MUI and TBOI
One day after hospitalization
The negative predictive value of OFI,MUI and TBOI
One day after hospitalization
The positive likelihood ratio of OFI,MUI and TBOI
One day after hospitalization
The negative likelihood ratio of OFI,MUI and TBOI
One day after hospitalization
Study Arms (1)
Experimental group
Patients will undergo pelvic X-ray examinations. Measurement indicators will include OFI, MUI, TBOI, CE angle, Sharp angle and AHI of the affected and healthy femoral heads. The investigators will determine the sensitivity and specificity of OFI, MUI and TBOI for the diagnosis of adult acetabular dysplasia, and compare the accuracy of diagnosis between these three indicators and CE angle, sharp angle, and AHI. Further analysis of risk factors for hip function will be implemented.
Interventions
Measurement indicators will include OFI, MUI, TBOI, CE angle, Sharp angle and AHI of the affected and healthy femoral heads.
Eligibility Criteria
Potential patients will be informed of the study details through an announcement issued through the bulletin board of the Third Hospital of Hebei Medical University. Interested patients will directly contact the principle investigator via telephone, and among them, eligible patients will be required to provide written consent prior to the participation in the trial.
You may qualify if:
- No experience in hip replacement, pelvic fixation or external fixation, and proximal femoral surgery;
- No marked pelvic tilt;
- No hip dislocation;
- No obvious hip deformity, such as significant collapse of the femoral head and severe hip traumatic arthritis;
- No significant lesions in the pelvis or proximal femur;
- Aged over 16 years;
- Provision of written informed consent.
You may not qualify if:
- Those with advanced osteoarthritis;
- Those with osteoarthritis secondary to acetabular dysplasia;
- Those with ankylosing spondylitis involving the hip joint;
- Those with rheumatoid arthritis;
- Those with inflammatory inflammation of the hip joint;
- Those with tumor lesions in the hip joint.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050051, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Di Qin, M.S.
Third Hospital of Hebei Medical University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 17, 2018
First Posted
May 30, 2018
Study Start
February 1, 2018
Primary Completion
October 1, 2019
Study Completion
December 1, 2019
Last Updated
May 30, 2018
Record last verified: 2018-05